DYDX Capital — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Cime Therapeuticscimetherapeutics.comin𝕏Mar 2025
BiotechDenver, US
James Thomas Brewster II(Executive Officer, Director)James Brewster(Chief Executive Officer)Patrick Barbour(Associate Director)Gregory Thiabaud(Associate Director)
BoardChris Erickson(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.